Philip N Collier Selected Research

pyrazolopyridine

8/2019

Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip N Collier Research Topics

Disease

2	Multiple Sclerosis 08/2019 - 01/2018
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 12/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2019
1	Hepatitis C 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 03/2013

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 01/2016 - 03/2013
1	EnzymesIBA 12/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	Protein Kinases (Protein Kinase)IBA 08/2019
1	AminesIBA 08/2019
1	oxetaneIBA 08/2019
1	pyrazolopyridineIBA 08/2019
1	Protein Isoforms (Isoforms)IBA 01/2018
1	LipidsIBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA 01/2018
1	ThiophenesIBA 01/2016
1	Viral ProteinsIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Protein Kinase CIBA 03/2013

Therapy/Procedure

1	Therapeutics 01/2016